Logistics & Transportation

Articles

The San Antonio facility will be taking this biomanufacturing initiative by the end of Q3 2024.

Scorpius to Unveil First Mammalian cGMP Campaign at Texas Plant

The deal exponentially grows the CDMO’s biopharma capabilities.

Agilent Purchases Biovectra for $925 Million

In a transaction valued at $250 million, the deal makes Grünenthal the new owner of Movantik, which treats OIC in adult patients with chronic non-cancer pain. 

Grünenthal Obtains Valinor Pharma 

Analyzing the divergent paths undertaken by small biotech and large pharma companies in drug development. 

Bridging the Divide: Understanding Contrasting Approaches in Drug Development

The financial commitment includes a pair of expansion plans occurring in the United States and Europe. 

Cordenpharma Invests $984 Million into Its Peptide Tech Platform

The 50,000 square-foot facility has the ability to handle various batch sizes and dosage forms. 

Upperton Pharma Solution Passes MHRA Inspection, Simultaneously Invests in Large-Scale Processing

The construction of 100,000 square-foot facility will boost the site's filling capacity to 140 million units per year.

INCOG BioPharma Invests in Second Manufacturing Building on Indiana Campus

New production line represents Rentschler Biopharma SE’s biggest investment in its 150-year history. 

Rentschler Biopharma SE’s New Advanced Production Line Now Fully Operational 

The merger combines the companies under the MedPharma name, creating a topical and transepithelial CDMO in the process. 

MedPharm, Tergus Pharma Join Forces

The deal provides the CDMO with ownership of the Lexington facility, allowing for late-phase and commercial gene therapy development and manufacturing of a branded severe Hemophilia B product. 

Manufacturing & Packaging